60-Day IL
Injury Elbow
Est. Return 2/1/2025
2024 Stats
W-L
0-0
ERA
0.00
WHIP
0.00
K
0
SV
0
Rest-of-Season Projections
Recovering from Tommy John surgery
McFarlane, who underwent Tommy John surgery in September, was placed on Single-A Clearwater's 60-day injured list March 20 and will miss the 2024 season, Jonathan Mayo of MLB.com reports.
ANALYSIS
The timing of McFarlane's procedure should allow him to be fully recovered for spring training in 2025. The 22-year-old righty has big stuff and shaky command and could eventually end up in the bullpen.
The timing of McFarlane's procedure should allow him to be fully recovered for spring training in 2025. The 22-year-old righty has big stuff and shaky command and could eventually end up in the bullpen.
Pitching Stats
Loading Pitching Stats...
Minor League Game Log
Calculate Stats Over Time
Just click on any two dates.
Loading Minor League Pitching Game Log...
Prospect Rankings History
Advanced Pitching Stats
Loading Advanced Pitching Stats...
Defensive Stats
Loading MLB Defensive Stats...
Stats Vs Today's Lineup
Want more matchup stats?
Loading Matchup Stats...
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Alex McFarlane See More
James Anderson breaks down this year's most notable minor-league assignments, including the Rangers aggressively sending toolsy infielder Sebastian Walcott to High-A as an 18-year-old.
James Anderson goes team-by-team to highlight which pitching prospects could ascend to the closer role in the coming years, including A's righty Mason Miller.
More Fantasy News
Lands on IL
Single-A Clearwater placed McFarlane on its 7-day injured list Saturday with an unspecified injury.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Selected 122nd overall
The Phillies have selected McFarlane with the 122nd overall pick in the 2022 first-year player draft.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.